Pharmacology and clinical experience with fedotozine

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/13543784.10.1.97PMID 11116283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by kappa-opioids.

  2000cited by this paper
• Fedotozine, a kappa‐opioid agonist, prevents spinal and supra‐spinal Fos expression induced by a noxious visceral stimulus in the rat

  2000cited by this paper
• Effect of opioid active therapeutics on the ascending reflex pathway in the rat ileum.

  2000cited by this paper
• Mechanical activation of dorsal root ganglion cells in vitro: comparison with capsaicin and modulation by κ-opioids

  2000cited by this paper
• Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis

  2000cited by this paper
• Glutamine in parenteral nutrition: more food for thought

  1999cited by this paper
• Effects of kappa opioids in the inflamed rat colon.

  1999cited by this paper
• Fundamentals of neurogastroenterology

  1999cited by this paper
• Principles of applied neurogastroenterology: physiology/motility–sensation

  1999cited by this paper
• Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention.

  1999cited by this paper
• The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.

  1999cited by this paper
• The functional gastrointestinal disorders and the Rome II process

  1999cited by this paper
• The κ agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome

  1999cited by this paper
• The discriminative stimulus properties of U50,488 and morphine are not shared by fedotozine.

  1998cited by this paper
• The Contractile Effect of Fedotozine on Guinea Pig Isolated Intestinal Cells Is Not Mediated by Kappa Opioid Receptors

  1998cited by this paper
• Effects of rectal distensions on nociceptive flexion reflexes in humans.

  1998cited by this paper
• Effects of rectal distensions on nociceptive flexion reflexes in humans.

  1998cited by this paper
• Effects of mu- and kappa-opioid receptors on postoperative ileus in rats.

  1997cited by this paper
• Fedotozine blocks hypersensitive visceral pain in conscious rats: action at peripheral kappa-opioid receptors.

  1997cited by this paper
• Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations.

  1997cited by this paper
• Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia

  1997cited by this paper
• Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans

  1996cited by this paper
• International Union of Pharmacology. XII. Classification of opioid receptors.

  1996cited by this paper
• Neuronal pathways involved in abdominal surgery-induced gastric ileus in rats.

  1996cited by this paper
• Kappa, but not mu or delta, opioids attenuate responses to distention of afferent fibers innervating the rat colon.

  1996cited by this paper
• Differential effects of fedotozine compared to other kappa agonists on diuresis in rats.

  1996cited by this paper
• [Animal models of intestinal inflammation].

  1995cited by this paper
• Fedotozine reversal of peritoneal-irritation-induced ileus in rats: possible peripheral action on sensory afferents.

  1994cited by this paper
• Effect of fedotozine on the cardiovascular pain reflex induced by distension of the irritated colon in the anesthetized rat.

  1994cited by this paper
• Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome.

  1994cited by this paper
• Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.

  1994cited by this paper
• Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.

  1994cited by this paper
• Peripheral κ-opioid receptors mediate the antinociceptive effect of fetodozine on the duodenal pain reflex in rat

  1994cited by this paper
• Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia

  1994cited by this paper
• The kappa agonist fedotozine modulates colonic distention-induced inhibition of gastric motility and emptying in dogs.

  1994cited by this paper
• The effects of sleep deprivation on rectal sensitivity on healthy volunteers

  1993cited by this paper
• Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.

  1993cited by this paper
• Fedotozine reverses ileus induced by surgery or peritonitis: action at peripheral kappa-opioid receptors.

  1993cited by this paper
• Changes in anorectal function in persistent bowel disturbance following salmonella gastroenteritis

  1993cited by this paper
• Effects of selective opioid agonists on feline colonic transit.

  1991cited by this paper
• Interaction of trimebutine and Jo-1196 (fedotozine) with opioid receptors in the canine ileum.

  1991cited by this paper
• Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin

  1990cited by this paper
• Effects of Fedotozine on Gastrointestinal Motility in Dogs: Mechanism of Action and Related Pharmacokinetics

  1990cited by this paper
• Antagonism of Stress‐Induced Gastric Motor Alteration and Plasma Cortisol Release by Fedotozine (JO 1196) in Dogs

  1990cited by this paper
• Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.

  1989cited by this paper
• Stimulation of kappa opiate receptors in intestinal wall affects stress-induced increase of plasma cortisol in dogs.

  1989cited by this paper
• Vagally mediated inhibition of acoustic stress-induced cortisol release by orally administered kappa-opioid substances in dogs.

  1989cited by this paper
• Opposite effects of κ-opioid agonists on gastric emptying of liquids and solids in dogs

  1988cited by this paper
• Opposite effects of kappa-opioid agonists on gastric emptying of liquids and solids in dogs.

  1988cited by this paper
• 7 Action of opiates on gastrointestinal function

  1988cited by this paper
• Action of opiates on gastrointestinal function.

  1988cited by this paper
• Opioid Analgesia at Peripheral Sites: A Target for Opioids Released during Stress and Inflammation?

  1987cited by this paper
• Axonal transport of opiate receptors in capsaicin-sensitive neurones.

  1984cited by this paper
• II - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists.

  1979cited by this paper
• Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome 1

  1973cited by this paper

• The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies

  2022cites this paper
• Postoperative Follow-Up and Recovery after Abdominal Surgery

  2021cites this paper
• 12 Postoperative Ileus : Pathophysiology and Treatment

  2018cites this paper
• Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation

  2017cites this paper
• Asymmetric synthesis of vicinal amino alcohols via organocatalytic sequential α-amination/Grignard addition reactions of aldehydes

  2017cites this paper
• Opioid κ Receptors as a Molecular Target for the Creation of a New Generation of Analgesic Drugs

  2016cites this paper
• Enantioselective rhodium-catalyzed arylation of cyclic N-sulfamidate alkylketimines: a new access to chiral β-alkyl-β-aryl amino alcohols.

  2014cites this paper
• Postoperative Ileus: Pathophysiology and Treatment

  2012cites this paper
• Drug Management of Visceral Pain: Concepts from Basic Research

  2012cites this paper
• New Developments in the Treatment of Functional Dyspepsia

  2012cites this paper
• Psihotropna biljna vrsta Salvia divinorum Epl. & Jativa - izvor najpotentnijeg halucinogena u prirodi

  2010cites this paper
• Analgesic Efficacy of Peripheral &kgr;-Opioid Receptor Agonist CR665 Compared to Oxycodone in a Multi-modal, Multi-tissue Experimental Human Pain Model: Selective Effect on Visceral Pain

  2009cites this paper
• Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development

  2009cites this paper
• Chapter 57 – GASTROINTESTINAL DYSFUNCTION WITH OPIOID USE

  2009cites this paper
• Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome

  2008cites this paper
• Opioid-Induced Gastrointestinal Dysfunction

  2006cites this paper
• Aspectos específicos de la anestesia en cirugía abdominal por laparotomía en el adulto

  2006cites this paper
• Antinociceptive profile of salvinorin A, a structurally unique kappa opioid receptor agonist.

  2006cites this paper
• Drugs Affecting Visceral Sensitivity: Ready for the Prime Time?

  2006cites this paper
• Aspects spécifiques de l'anesthésie en chirurgie abdominale par laparotomie de l'adulte

  2005cites this paper
• Different aspects in functional dyspepsia.

  2005cites this paper
• Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.

  2005cites this paper
• Diagnosis and treatment of noncardiac chest pain

  2005cites this paper
• Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control

  2005cites this paper
• Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A.

  2003cites this paper
• The pharmacology of gastrointestinal nociceptive pathways.

  2002cites this paper
• Noncardiac Chest Pain

  2002influential citation
• Evolving concepts in functional gastrointestinal disorders: promising directions for novel pharmaceutical treatments.

  2002cites this paper
• Emerging treatments for irritable bowel syndrome

  2002cites this paper
• Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.

  2002cites this paper
• Review of postoperative ileus.

  2001cites this paper
• Irritable bowel syndrome: an update on therapeutic modalities

  2001cites this paper
• [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].

  2001cites this paper
• Pathophysiology and Treatment

  2000cites this paper